中国麻风皮肤病杂志 ›› 2019, Vol. 35 ›› Issue (12): 765-768.doi: 10.12144/zgmfskin201912765

• 综述 • 上一篇    

抗抑郁药在带状疱疹后遗神经痛治疗中的研究进展

周沪程1,2,罗凤林1,2,许辉1,2,李遇梅1,2   

  1. 1江苏大学附属医院,江苏镇江,212001
    2江苏大学再生医学研究院,江苏镇江,212001

  • 出版日期:2019-12-15 发布日期:2019-12-25
  • 通讯作者: 李遇梅,E-mail:yumeili@ujs.edu.cn

Update of antidepressants in the treatment of postherpetic neuralgia

ZHOU Hucheng1,2, LUO Fenglin1,2, XU Hui1,2, LI Yumei1,2   

  1. 1. The Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China; 
    2. Jiangsu University Institute of Regenerative Medicine, Zhenjiang 212001, China
  • Online:2019-12-15 Published:2019-12-25
  • Contact: LI Yumei, E-mail: yumeili@ujs.edu.cn

摘要: 带状疱疹后遗神经痛是神经病理性疼痛的一种,常给患者带来巨大的身心负担,严重影响患者的社会功能和生活质量。目前治疗PHN有多种镇痛方案,其中抗抑郁药是公认的一线用药。三环类抗抑郁药在治疗PHN中的有效性已被证实,而5羟色胺去甲肾上腺素再摄取抑制剂有待进一步验证。本文总结了抗抑郁药在治疗带状疱疹后遗神经痛中的研究进展并建议应用联合疗法,以减低抗抑郁药的单药剂量,降低不良反应,提高镇痛效果。

关键词: 抗抑郁药, 带状疱疹后遗神经痛, 联合疗法

Abstract: Postherpetic neuralgia (PHN) is a kind of neuropathic pain, which often brings huge physical and mental burden to patients and seriously affects the social function and quality of life. At present, there are various analgesic schemes for the treatment of PHN, and antidepressants have been recognized as first-line medications for treatment. The effectiveness of tricyclic antidepressants in treating PHN has been verified, while serotonin norepinephrine reuptake inhibitors need further validation. The update of antidepressants in the treatment of postherpetic neuralgia is summarized in this paper. We propose combination therapy in order to improve analgesic effect and reduce the dose of monotherapy and adverse reactions.

Key words: antidepressants, postherpetic neuralgia, combination therapy